Category: Dengue
Global Dengue
-
The 2025-2030 World Outlook for Enzyme-Linked-Immunosorbent-Assay-Based (ELISA-Based) Dengue Tests
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Tropical Disease Testing Products
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
Global Dengue Virus Diagnostic Tests Market Growth (Status and Outlook) 2024-2030
... With growing demand in downstream market, the Dengue Virus Diagnostic Tests is forecast to a readjusted size of US$ 4122.9 million by 2030 with a CAGR of 3.8% during review period. The research report highlights ... Read More
-
Global Dengue Vaccines Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... of the Dengue Vaccines industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Dengue Vaccines. The report also introduces players in the industry ... Read More
-
Diagnostic Specialty Antibodies Market by Antibody (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Polyclonal Antibodies), Application (Dengue Diagnostics, Hepatitis Diagnosis, HIV Diagnostics), End User - Global Forecast 2024-2030
... USD 23.11 billion in 2023 and expected to reach USD 24.36 billion in 2024, at a CAGR 5.49% to reach USD 33.60 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Neglected Tropical Disease Treatment Market by Product (Drugs, Vaccines), Types of Diseases (Buruli Ulcer, Chagas Disease, Dengue), Diagnostic Method - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 6.40 billion in 2024, at a CAGR 6.25% to reach USD 9.38 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Dengue Testing Market by Type (Dengue IgG/IgM Rapid Test, ELISA-based Test, Real-Time RT-PCR Test), Component (Instruments & Equipments, Laboratory Consumables, Software & Data Management Solutions), End-User - Global Forecast 2024-2030
... was estimated at USD 499.78 million in 2023 and expected to reach USD 527.02 million in 2024, at a CAGR 5.71% to reach USD 737.69 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Therapeutic Vaccines Market by Vaccines Type (Auto-Immune Diseases Vaccines, Chronic Disease Vaccines, Infectious Diseases Vaccines), Disease Indication (Dengue, DTP, Hepatitis), Administration, End-User - Global Forecast 2024-2030
... 30.08 billion in 2023 and expected to reach USD 33.05 billion in 2024, at a CAGR 10.35% to reach USD 59.95 billion by 2030. Global Therapeutic Vaccines Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Global Dengue Testing Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... of the Dengue Testing industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Dengue Testing. The report also introduces players in the industry ... Read More
-
Dengue Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 761.6 Million by 2028, exhibiting a growth rate (CAGR) of 5.2% during 2023-2028. Dengue, also known as breakbone fever, is a viral infection that spreads through the bite of an infected Aedes aegypti ... Read More
-
Dengue Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dengue Fever - Drugs In Development, 2022, provides an overview of the Dengue Fever (Infectious Disease) pipeline landscape. Dengue is a mosquito borne infectious disease ... Read More
-
Global Preventive Vaccine Market - 2023-2030
... 5.3% during the forecast period (2023-2030). A preventive vaccine is a kind of biological preparation which stimulates immunity to a specific pathogen. A vaccine commonly contains an agent similar to the disease-causing microbe and is ... Read More
-
Global Neglected Tropical Disease Treatment Market - 2022-2029
... growing at a CAGR of 5.55% during the forecast period (2022-2029). Neglected tropical diseases (NTDs) are a series of 20 diseases mostly found in tropical areas, disproportionately impacting poor people, women and children. People suffer ... Read More
-
Global Neglected Tropical Diseases Diagnosis Market Size study, by Disease (Dengue, Chikungunya, Rabies, Lymphatic Filariasis, Buruli Ulcer, Foodborne Trematodiases, Echinococcosis, Leprosy, Yaws, Taeniasis/Cysticercosis, Chagas Disease (American Trypanosomiasis), Dracunculiasis, African Trypanosomiasis, Soil-transmitted Helminth Infections, Onchocerciasis, Schistosomiasis, Scabies and Other Ectoparasites, Snakebite Envenoming, Leishmaniasis, and Others), By Diagnostic (Conventional, Molecular/Modern), By Service Type (Centralized Service, POC Service), By End-use (Hospitals and Clinics, Home Healthcare, Clinical Laboratories) and Regional Forecasts 2022-2028
... Scabies and Other Ectoparasites, Snakebite Envenoming, Leishmaniasis, and Others), By Diagnostic (Conventional, Molecular/Modern), By Service Type (Centralized Service, POC Service), By End-use (Hospitals and Clinics, Home Healthcare, Clinical Laboratories) and Regional Forecasts 2022-2028 Global Neglected ... Read More
-
Global Neglected Tropical Diseases Diagnosis Market - 2022-2029
... growing at a CAGR of XX % during the forecast period (2022-2029). Neglected tropical diseases (NTDs) are a series of 20 diseases mostly found in tropical areas, where they disproportionately impact poor people, women and ... Read More
-
Dengue Vaccines Market, By End User (Hospitals, Government Institutes, NGOs), and By Region (Latin America, Middle East, Africa, and Rest of World) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... a mosquito-borne viral infection causing a severe flu-like illness. Dengue vaccine is only recommended in those who have previously had dengue fever. It is given as three injections over a year. Dengue is most likely ... Read More
Research Assistance
